✦ LIBER ✦

In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis

✍ Scribed by Gui-Sheng Li; Wang-Lin Jiang; Jing-Wei Tian; Gui-Wu Qu; Hai-Bo Zhu; Feng-Hua Fu

Book ID: 113848537
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 692 KB
Volume: 17
Category: Article
ISSN: 0944-7113
DOI: 10.1016/j.phymed.2009.05.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

379 Antifibrotic activity of refanlin, a

379 Antifibrotic activity of refanlin, a hepatocyte growth factor analogue in vitro and in experimental liver fibrosis

✍ Carlos Alvarez; Peter Mento; Prakash Narayan; Itzhak D. Goldberg; Scott Friedman 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

329 In vitro and in vivo antifibrotic ef

329 In vitro and in vivo antifibrotic effects of thalidomide

✍ L.-W. Chong; Y.-T. Huang 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Antifibrotic effects of glycyrrhizin and

Antifibrotic effects of glycyrrhizin and matrine in vitro and in vivo

✍ Jun Zhao; Xu-ying Wan; Ming Luo; Ting-song Chen; Ping He 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 863 KB

Additive antifibrotic effects of pioglit

Additive antifibrotic effects of pioglitazone and candesartan on experimental renal fibrosis in mice

✍ KEISHI HIGASHI; TAKASHI ODA; TAKETOSHI KUSHIYAMA; TOSHITAKE HYODO; MUNEHARU YAMA 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 773 KB

Hemodynamic and antifibrotic effects of

Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension

✍ Vincent Croquet; Frédéric Moal; Nary Veal; Jianhua Wang; Frédéric Oberti; Jérôme 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Antifibrotic effects of a tissue inhibit

Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats

✍ Christopher J. Parsons; Blair U. Bradford; Clark Q. Pan; Ellen Cheung; Michael S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB 👁 1 views

Liver fibrosis is characterized by increased synthesis, and decreased degradation, of extracellular matrix (ECM) within the injured tissue. Decreased ECM degradation results, in part, from increased expression of tissue inhibitor of metalloproteinase-1 (TIMP-1), which blocks matrix metalloproteinase